The Atara Story

We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options combat cancer and other serious illnesses. Our research is based on groundbreaking discoveries regarding the ability to harness and augment the immune system to stem disease as well as the ability of activin, myostatin and other growth factors to change the course of disease progression. Our goal is to help patients such as Atara Ciechanover, our company’s namesake, who suffered from cancer before passing away in 2012. We aim to empower patients to fight their illnesses with better treatment options.